Interactive virtual reality can help radiologists, surgeons work better together.
Interoperability was a buzz word on steroids at HIMSS. It was found in big letters within many of the prominent booths all over the show.
Interoperability demands that communications regarding all aspects of patient care be connected, from entry into the system to discharge. This is required to realize the best results for increasing patient outcomes. However, this can't properly happen if departments, such as radiology and surgery, do not effectively talk with each other – something that often occurs due to the lack of a common visualization language.
This was confirmed at HIMSS by discussing this matter with many C- and IT-level individuals. They did confirm, after participating in a demo, that interactive virtual reality (IVR) has the potential to resolve the communication issue.
Why might this be true? For radiology, the "object" views (vs current limitation of using only image views) of IVR will allow radiology to "speak intelligently with surgeons." For surgeons, the “object” views of IVR is, by definition, the representation of the anatomical world of the surgeon. As one surgeon stated, “I've never opened up a patient and seen a 2D view.”
I won't be so bold as to say that IVR is the "key" ingredient to realizing interoperability. However, I will be so bold as to say that the proven, significant gains of both clinical efficacy and workflow (using IVR) are "key" ingredients to increasing patient outcomes. The enhancement of patient engagement due to IVR has been shown to further increase patient outcomes.[[{"type":"media","view_mode":"media_crop","fid":"46856","attributes":{"alt":"Ronald Schilling, PhD","class":"media-image media-image-right","id":"media_crop_6255425767733","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5467","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 144px; width: 180px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"Ronald Schilling, PhD","typeof":"foaf:Image"}}]]
An editorial report summarizing HIMSS said:
“At HIMSS16 buzzwords are dead (including big data, interoperability, personalized medicine, population health, etc.) It’s about innovating at all costs,” Dr. John D. Halamka, CIO for Harvard Medical School, wrote for MedCity News. “We will no longer be driven by compliance imperatives (Meaningful Use, HIPAA, Affordable Care Act, and ICD10), but instead will need to improve outcomes in order to survive financially. No one is completely sure how to do that, but there are enablers.”
Interoperability is not dead. Based on meaningful use of IVR, interoperability can finally realize its potential in improving patient outcomes. That’s where innovation will come into play.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.